SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
MBC reported Q3 2026 results. The stock moved -5.1% on the print.
MBCearnings

Earnings reactions, page 6

MasterBrand, Inc. (MBC) Q3 FY2026 earnings

November 6, 2026 · SharpeIQ Research Desk

Reported results

  • Net sales were $1,036.8 million under GAAP.
  • Net loss was $(9.2) million and net loss margin was (0.9)% under GAAP.
  • Adjusted EBITDA was $86.0 million, representing an adjusted EBITDA margin of 8.3% (non-GAAP).
  • Diluted loss per share was $(0.05) under GAAP, and adjusted diluted earnings per share was $0.10 (non-GAAP).
  • Gross profit was $254.9 million and gross profit margin was 24.6% under GAAP.

Guidance

  • Net sales of $958 to $988 million for the fourth quarter of 2026
  • Adjusted EBITDA in the range of $38 to $48 million, with related adjusted EBITDA margin in the range of 4.0% to 4.9% for the fourth quarter of 2026 (non-GAAP)
  • Adjusted diluted loss per share in the range of $(0.12) to $(0.08) for the fourth quarter of 2026 (non-GAAP)
  • Gross tariff costs of approximately 5-6% of full-year 2026 net sales
  • Free cash flow for full-year 2026 expected to be approximately breakeven (non-GAAP)

Price and volatility reaction

The stock moved -5.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +3.8 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release7.082026-11-05
Close after release6.722026-11-06
Realised move-5.1%close to close
30d ATM IV change+3.8 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →